01011 泰凌醫藥
公司資料 - 損益表
中國泰凌醫藥集團有限公司 股票編號: 01011
CHINA NT PHARMA GROUP COMPANY LIMITED 集團網址: http://www.ntpharma.com
2024/12 - 末期
人民幣(¥)
變動 2023/12
人民幣(¥)
2022/12
人民幣(¥)
2021/12
人民幣(¥)
2020/12
人民幣(¥)
營業額 / 收益37,960,000415.341%7,366,000207,092,000226,699,000221,731,000
銷售成本(32,700,000)----(81,806,000)(81,240,000)(86,827,000)
毛利5,260,000----125,286,000145,459,000134,904,000
 
投資物業公平值變動及減值------(78,000)--10,980,000
其他項目公平值變動及減值(5,922,000)------(14,011,000)(68,706,000)
出售項目溢利 / (虧損)----12,272,000------
其他非經營項目(7,009,000)----(11,318,000)(5,807,000)--
分佔聯營公司及共同控制公司業績10,244,000-72.343%37,039,0009,003,00034,490,0008,000
除稅前溢利 / (虧損)(53,480,000)60.269%(33,369,000)(54,296,000)(148,752,000)(200,289,000)
稅項123,000--(122,000)(12,109,000)(2,582,000)9,020,000
已終止經營業務溢利 / (虧損)----(110,099,000)----(168,644,000)
非控股權益0--001,796,0002,314,000
其他項目------------
股東應佔溢利 / (虧損)(53,357,000)-62.841%(143,590,000)(66,405,000)(149,538,000)(357,599,000)
 
淨財務支出 / (收入)31,533,0009.455%28,809,00071,710,00088,488,00083,702,000
折舊及攤銷660,000-45.589%1,213,00021,070,00042,249,00024,397,000
董事酬金----2,231,0003,609,0003,774,0004,417,000
 
核數師意見不表示意見--不表示意見不表示意見不表示意見無保留意見 (修定報告)
 
市場價值指標
每股盈利 (仙)-20.200---60.200-34.900-79.100-189.500
每股派息 (仙)0.000--0.0000.0000.0000.000
派息比率 (%)------------
每股現金流 ($)----0.2120.191-0.0720.014
每股帳面資產淨值 ($)-1.511---1.286-1.269-1.1100.085
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.